{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:22:02Z","timestamp":1789683722164,"version":"4.0.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Renal cell carcinoma (RCC) has been traditionally thought to be radioresistant. This retrospective cohort study aims to assess the outcomes of patients with spinal metastases from RCC treated with conventionally-fractionated external beam radiation therapy (cEBRT) in our institution.<\/jats:p>\n            <jats:p>Patients diagnosed with histologically or radiologically-proven RCC who received palliative cEBRT to spinal metastases, using 3-dimensional conformal technique between 2009 and 2018 were reviewed. Local progression-free survival (PFS), overall survival (OS) and common terminology criteria for adverse events version 4.0-graded toxicity were assessed. Univariable and multivariable Cox proportional hazards regression analyses were performed to evaluate for predictors associated with survivals.<\/jats:p>\n            <jats:p>Thirty-five eligible patients with forty spinal segments were identified, with a median follow-up of 7 months (range, 0\u201347). The median equivalent dose in 2 Gy fractions (EQD<jats:sub>2<\/jats:sub>) was 32.5 Gy <jats:sub>10<\/jats:sub> (range, 12\u201339). Thirty-seven percent of patients underwent surgical intervention. At the time of last follow-up, all but 1 patient had died. Seven patients developed local progression, with the median time to local progression of 10.2 months. The median local PFS and OS were 3.3 and 4.8 months. There was no grade 3 or higher toxicity. A higher radiation dose (equivalent dose to 2 Gy fraction &lt;32.5 Gy <jats:sub>10<\/jats:sub> vs \u226532.5Gy <jats:sub>10<\/jats:sub>) (hazard ratio [HR], 0.47; 95% confidence interval [CI], 0.17\u20133.18; <jats:italic toggle=\"yes\">P<\/jats:italic>-value (<jats:italic toggle=\"yes\">P<\/jats:italic>) = .68) and spinal surgery (HR, 2.35; 95% CI, 0.53\u201310.29; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.26) were not significantly associated with local PFS on univariable analysis. Multivariable analysis showed that higher Tokuhashi score (HR, 0.41; 95% CI, 0.19\u20130.88; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.02), lower number of spinal segments irradiated (HR, 1.18; 95% CI, 1.01\u20131.37; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.04) and use of targeted therapy (HR, 0.41; 95% CI, 0.18\u20130.96; <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.04) were independent predictors for improved OS.<\/jats:p>\n            <jats:p>For an unselected group of patients with RCC, there is no significant association between higher radiation dose and improved local control following cEBRT. This may be due to their short survivals. With the use of more effective systemic therapy, including targeted therapy and immunotherapy, survival will likely be prolonged. A tailored-approach is needed to identify patients with good prognosis who may still benefit from aggressive local treatments.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019838","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T15:45:52Z","timestamp":1587224752000},"page":"e19838","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of patients with spinal metastases from renal cell carcinoma treated with conventionally-fractionated external beam radiation therapy"],"prefix":"10.1097","volume":"99","author":[{"given":"Chia Ching","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, National University Cancer Institute, Singapore; National University Hospital, Singapore; National University Health System, Singapore; National University of Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy Chee Seong","family":"Tey","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National University Cancer Institute, Singapore; National University Hospital, Singapore; National University Health System, Singapore; National University of Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Cheo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National University Cancer Institute, Singapore; National University Hospital, Singapore; National University Health System, Singapore; National University of Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau Hung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Tan Tock Seng Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, National University Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, National University Hospital, Singapore; National University Health System, Singapore; National University of Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurugan","family":"Vellayappan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National University Cancer Institute, Singapore; National University Hospital, Singapore; National University Health System, Singapore; National University of Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"key":"R1-20230915","first-page":"73","article-title":"Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities","volume":"2","author":"Graves","year":"2013","journal-title":"Immunotargets Ther"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bju.12950","article-title":"Renal cell cancer histological subtype distribution differs by race and sex","volume":"117","author":"Lipworth","year":"2016","journal-title":"BJU Int"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/annonc\/mdr362","article-title":"Distribution of metastatic sites in renal cell carcinoma: a population-based analysis","volume":"23","author":"Bianchi","year":"2012","journal-title":"Ann Oncol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2519::AID-CNCR26>3.0.CO;2-E","article-title":"Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts","volume":"80","author":"Ning","year":"1997","journal-title":"Cancer"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0360-3016(95)02029-2","article-title":"A review of human cell radiosensitivity in vitro","volume":"34","author":"Deschavanne","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrurol.2017.87","article-title":"Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach","volume":"14","author":"Siva","year":"2017","journal-title":"Nat Rev Urol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/1097-0142(19830215)51:4<614::AID-CNCR2820510411>3.0.CO;2-J","article-title":"The role of radiation therapy in the management of metastatic renal cell carcinoma","volume":"51","author":"Halperin","year":"1983","journal-title":"Cancer"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/0360-3016(85)90285-8","article-title":"Radiation therapy in the treatment of metastatic renal cell carcinoma","volume":"11","author":"Onufrey","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000473553","article-title":"Radiotherapy of metastases from renal cancer","volume":"8","author":"Fossa","year":"1982","journal-title":"Eur Urol"},{"key":"R10-20230915","first-page":"100","article-title":"Radiotherapy of metastatic renal cell carcinoma","volume":"4","author":"Seitz","year":"1988","journal-title":"Semin Surg Oncol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.critrevonc.2018.02.017","article-title":"Treatment of spinal metastases in renal cell carcinoma: a critical review","volume":"125","author":"Teyssonneau","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1016\/j.wneu.2017.10.011","article-title":"Radiosurgery for treatment of renal cell metastases to spine: a systematic review of the literature","volume":"109","author":"Smith","year":"2018","journal-title":"World Neurosurg"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2009.03.062","article-title":"Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy","volume":"76","author":"Nguyen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3171\/spi.2005.3.4.0288","article-title":"Stereotactic radiosurgery for spinal metastases from renal cell carcinoma","volume":"3","author":"Gerszten","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3171\/2015.8.SPINE15844","article-title":"Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I\/II trials","volume":"24","author":"Ghia","year":"2016","journal-title":"J Neurosurg Spine"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2152-7806.200581","article-title":"Stereotactic spine radiosurgery: review of safety and efficacy with respect to dose and fractionation","volume":"8","author":"Huo","year":"2017","journal-title":"Surg Neurol Int"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jclinepi.2006.11.004","article-title":"The need for reappraisal of AIDS score weight of Charlson comorbidity index","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2006.09.034","article-title":"Grading systems in renal cell carcinoma","volume":"177","author":"Novara","year":"2007","journal-title":"J Urol"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/cncr.22463","article-title":"Prognostic ability of simplified nuclear grading of renal cell carcinoma","volume":"109","author":"Rioux-Leclercq","year":"2007","journal-title":"Cancer"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(12)70559-4","article-title":"External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study","volume":"14","author":"Heng","year":"2013","journal-title":"Lancet Oncol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","article-title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","volume":"378","author":"Motzer","year":"2018","journal-title":"N Engl J Med"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.brs.0000180401.06919.a5","article-title":"A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis","volume":"30","author":"Tokuhashi","year":"2005","journal-title":"Spine (Phila Pa 1976)"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1200\/JCO.2010.34.3897","article-title":"Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group","volume":"29","author":"Fourney","year":"2011","journal-title":"J Clin Oncol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","article-title":"Reliability analysis of the epidural spinal cord compression scale","volume":"13","author":"Bilsky","year":"2010","journal-title":"J Neurosurg Spine"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/cncr.21410","article-title":"A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma","volume":"104","author":"Lee","year":"2005","journal-title":"Cancer"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0360-3016(98)00021-2","article-title":"Radiotherapy for metastatic carcinomas of the kidney or melanomas: an analysis using palliative end points","volume":"41","author":"Huguenin","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"6384253","DOI":"10.1155\/2018\/6384253","article-title":"The efficacy of conventionally fractionated radiation in the management of osseous metastases from metastatic renal cell carcinoma","volume":"2018","author":"Ganju","year":"2018","journal-title":"J Oncol"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5301\/tj.5000370","article-title":"Stability of spinal bone metastases and survival analysis in renal cancer after radiotherapy","volume":"101","author":"Schlampp","year":"2015","journal-title":"Tumori"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2005.11.004","article-title":"Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: results of a retrospective multi-center study","volume":"49","author":"Rades","year":"2006","journal-title":"Eur Urol"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0936-6555(03)00164-X","article-title":"The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma","volume":"15","author":"Wilson","year":"2003","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0022-5347(01)64305-2","article-title":"Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model","volume":"158","author":"DiBiase","year":"1997","journal-title":"J Urol"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/2192568217737777","article-title":"The challenges of renal cell carcinoma metastatic to the spine: a systematic review of survival and treatment","volume":"8","author":"Goodwin","year":"2018","journal-title":"Global Spine J"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s00586-015-3862-9","article-title":"Tokuhashi score is predictive of survival in a cohort of patients undergoing surgery for renal cell carcinoma spinal metastases","volume":"24","author":"Petteys","year":"2015","journal-title":"Eur Spine J"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3171\/2013.9.SPINE13158","article-title":"Factors affecting survival in 267 consecutive patients undergoing surgery for spinal metastasis from renal cell carcinoma","volume":"20","author":"Tatsui","year":"2014","journal-title":"J Neurosurg Spine"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","article-title":"Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience","volume":"23","author":"Patard","year":"2005","journal-title":"J Clin Oncol"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-014-1455-9","article-title":"Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study","volume":"119","author":"Sohn","year":"2014","journal-title":"J Neurooncol"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/j.prro.2012.01.005","article-title":"The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma","volume":"2","author":"Hunter","year":"2012","journal-title":"Pract Radiat Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:18:15Z","timestamp":1694823495000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019838","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}